Growing Market Presence Proov has demonstrated rapid expansion with multiple product launches, including the Empower perimenopause testing system and the PdG-test, indicating strong market demand for at-home women's health diagnostics. This provides opportunities to target health-conscious women seeking accessible fertility and menopause insights.

Award-Winning Innovation Receiving the Audience Choice Award at HITLAB and launching the first PdG-test positions Proov as an innovative leader in hormone-based reproductive health diagnostics. This innovative reputation can be leveraged to build trust with consumers and healthcare providers alike.

Expanding Customer Base Proov's diverse product line designed for fertility, ovulation tracking, and menopause management signals an opportunity to cross-sell complementary products to women across different reproductive stages, increasing customer lifetime value.

Partnership Opportunities Collaborations with partners like Wisp and ongoing research projects indicate a strategic openness to expanding distribution channels. Partnering with healthcare providers or fertility clinics can enhance product adoption and drive sales growth.

Investment Potential With a revenue range of 1M to 10M and recent venture backing, Proov presents a promising opportunity for sales expansion through targeted outreach to investors, as well as strategic alliances to accelerate product adoption in a growing femtech market.